“I Want to Breathe Better”: Help Appropriate Uncontrolled Asthma and COPD Patients

May 18 @ 11:30 am 12:15 pm PDT

Innovation Theater 4
Supported By: Sanofi and Regeneron


Program Description

Explore how type 2 inflammation impacts asthma and COPD, driving exacerbations. Learn about a randomized trial assessing FeNO, lung function, airway volume, and mucus burden in asthma. Discover an option that targets key drivers of inflammation, reduces exacerbations and improve lung function—helping patients breathe better.